Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. [electronic resource]
Producer: 20141021Description: 423-40 p. digitalISSN:- 1875-8908
- Acetylcholinesterase -- cerebrospinal fluid
- Alzheimer Disease -- cerebrospinal fluid
- Amyloid beta-Peptides -- cerebrospinal fluid
- Benzothiazoles
- Blotting, Western
- Butyrylcholinesterase -- cerebrospinal fluid
- Cholinesterase Inhibitors -- administration & dosage
- Donepezil
- Double-Blind Method
- Drug Therapy, Combination
- Fluorescence
- Follow-Up Studies
- Humans
- Indans -- administration & dosage
- Physostigmine -- administration & dosage
- Piperidines -- administration & dosage
- Thiazoles
- Time Factors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.